Clene is a clinical-stage biopharmaceutical company focused on the development of unique therapeutics for neurodegenerative diseases.

Pharmaceutical

Clene Nanomedicine

Clene Nanomedicine's headquarters in Salt Lake City, UT, United States

Rob Etherington

Kayla N.

Marjan Sepassi

Morgan Brown

Michael Hotchkin

Jerry Miraglia

Adam Dorfman

Mark Mortenson

Vallerie V. McLaughlin

Alison Mosca

David J. Matlin

John Stevens

Jonathon Gay

Reed Wilcox

The Clinical Operations and Quality Assurance team at Clene Nanomedicine is responsible for ensuring the successful execution of clinical trials and maintaining the highest standards of quality in drug development. This team oversees the design, implementation, and monitoring of clinical studies while also managing compliance with regulatory requirements and internal quality standards. By integrating clinical operations with quality assurance, the team ensures that all therapeutic candidates are developed safely and effectively for neurodegenerative diseases.

Clinical Operations and Quality Assurance

The Corporate Governance team at Clene Nanomedicine oversees the company's strategic direction and ensures compliance with regulatory standards. Composed of a diverse group of board members, this team is responsible for guiding corporate policies, fostering ethical practices, and safeguarding shareholder interests, all while supporting Clene's mission to develop innovative therapeutics for neurodegenerative diseases.

Corporate Governance

The Leadership Team at Clene Nanomedicine is responsible for setting the strategic direction of the company and overseeing the development of innovative therapeutics for neurodegenerative diseases. Comprising key executives such as the Chief Science Officer and Chief Development Officer, the team drives research initiatives, manages operational activities, and ensures financial stability, all while fostering collaboration to advance clinical programs and bring groundbreaking solutions to market.

Leadership Team

The Research and Development team at Clene Nanomedicine is dedicated to advancing innovative therapeutics for neurodegenerative diseases. Led by expert professionals, including the Head of Medical and Chief Science Officer, the team conducts cutting-edge research, develops micro and biological solutions, and engineers novel drug formulations to enhance patient outcomes and drive clinical success.

Research and Development

The Legal and Compliance team at Clene Nanomedicine ensures adherence to regulatory requirements and ethical standards in all business operations. They manage legal risks, oversee compliance with securities regulations, and provide guidance on corporate governance, while supporting the company's mission to develop innovative therapeutics for neurodegenerative diseases.

Clene Nanomedicine

Org chart

Board & advisors

Teams

Clinical Operations and Quality Assurance

Corporate Governance

Leadership Team

Research and Development

Legal and Compliance

Offices

Clene Nanomedicine

Org chart

Board & advisors

Teams

Clinical Operations and Quality Assurance

Corporate Governance

Leadership Team

Research and Development

Legal and Compliance

Offices

Related companies